


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.80%
-0.04%
-1.71%
+1.50%
CSTL
Castle Biosciences I
$40.09
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Investors confidence is positive
CSTL Price Performance
$39.94 (+0.38%)
$22.77 (+76.06%)
$15.32 (+161.68%)
$30.25 (+32.53%)
CSTL has High risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

CSTL overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Eps growth

Earnings decline YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
CSTL Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CSTL Street Sentiment is bullish and have negative views on the near-term outlook
Average key support and resistance price levels
What is CSTL current stock price?
What are CSTL stock strengths?
What is CSTL Risk Level?
What is CSTL market cap and volume?
What is CSTL current Stock IQ?
Should I buy CSTL stock right now?
Is CSTL a Strong Buy right now?
What does a 'Strong Buy' rating mean for CSTL?
What does a 'Strong Sell' rating mean for CSTL?
What factors influence CSTL's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.80%
-0.04%
-1.71%
+1.50%
CSTL
Castle Biosciences I
Current Price
$40.09
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Investors confidence is positive

CSTL Price Performance
$39.94 (+0.38%)
$22.77 (+76.06%)
$15.32 (+161.68%)
$30.25 (+32.53%)
CSTL Analysts Opinion
CSTL Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Eps growth

Earnings decline YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
CSTL Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CSTL Street Sentiment is bullish and have negative views on the near-term outlook
CSTL has High risk level based on volatility, sector strength, volume, investor confidence and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Low volume

Average key support and resistance price levels
CSTL Stock IQ
CSTL Latest Analysis
What Makes Castle Biosciences (CSTL) a Good Fit for Trend Investing. Castle Biosciences (CSTL) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our Recent Price Strength screen.
Wed Dec 24, 2025
Canaccord Genuity Maintains Castle Biosciences (CSTL) Buy Recommendation. Fintel reports that on December 22 2025 Canaccord Genuity maintained coverage of Castle Biosciences (NasdaqGM:CSTL) with a Buy recommendation. Analyst Price Forecast Suggests 7.02% Downside
Tue Dec 23, 2025
BTIG Maintains Castle Biosciences (CSTL) Buy Recommendation. Fintel reports that on December 12 2025 BTIG maintained coverage of Castle Biosciences (NasdaqGM:CSTL) with a Buy recommendation. Analyst Price Forecast Suggests 1.41% Upside
Fri Dec 12, 2025
Heres Why Trend Investors Would Love Betting on Castle Biosciences (CSTL) . Castle Biosciences (CSTL) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Mon Dec 8, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
CSTL Stock trends
CSTL Stock performance
CSTL Stock analysis
CSTL investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.